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Cancer imaging is now a vital part of cancer treatment as early detection and diagnosis can 
greatly influence patient’s prognosis, and a variety of cancer imaging modalities are used for detecting 
different types of tumours. For intraoperative imaging, organic small molecule-based activatable 
fluorescent probes have been developed to achieve rapid and sensitive detection of cancer that are 
otherwise often missed. These include gGlu-HMRG, a fluorescent probe for γ-glutamyltransferase 
(GGT) based on Hydroxymethyl Rhodamine Green (HMRG) scaffold, which has achieved rapid in 
vivo tumour detection with high tumour-to-background ratio. However, not all tumours can be 
characterised with single enzymatic activity, and to simultaneously visualize altered activities of 
multiple enzymes in cancer sites, other scaffolds with distinct spectroscopic properties from those of 
HMRG were desired. The introductory chapter discusses the current situation of various imaging 
modalities in clinical settings, in particular, the modalities utilising light. The advantages of using 
activatable probes and multicolour imaging are also discussed. 
 
There were no reported rhodamines bearing a hydroxymethyl group that could function as a 
scaffold for protease probes and have spectroscopic properties that could be differentiated from 
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HMRG. Thus, in Chapter 2, synthetic schemes and a novel rational design strategy to develop 
asymmetrically modified spirocyclising rhodamines bearing a hydroxymethyl group are introduced. 
Asymmetrical rhodamine derivatives were designed by extending alkyl chains from one of the 
unsubstituted amines of the xanthene moiety of HMRG. As a result, the maximum wavelengths of 
absorption and fluorescence were successfully shifted to longer wavelengths than that of HMRG. 
However, their equilibrium constants of intramolecular spirocyclization pKcycl (the pH at which the 
absorbance or fluorescence of the compound decreases to a half of the maximum value as a result of 
spirocyclization) were larger than that of HMRG, resulting in the elevation of background fluorescence 
at the physiological pH of 7.4. Thus, further optimisations were attempted to the equilibrium constant 
by introducing electron-withdrawing halogens at the 2 position of the xanthene moiety. This resulted 
in successful shifting of pKcycl without affecting the red-shifted wavelengths.  
Some of the resulting novel rhodamine derivatives had the suitable spectroscopic properties 
to be the scaffolds for fluorescent probes for protease activities. Their fluorescence was distinguishable 
from that of HMRG, and they preferentially took the intramolecular spirocyclised form before the 
protease reaction along with reduced absorption in the visible region. Upon reaction with the targeted 
proteases, they were converted to rhodamine derivatives that preferentially took the open form to show 
strong fluorescence. 
As a proof of concept, a red-shifted GGT probe, gGlu-HMJCR, was developed based on a 
novel asymmetrical rhodamine, HMJCR. gGlu-HMJCR was confirmed to activate and fluoresce in 
yellow/orange region of visible light upon reaction with GGT by in vitro and cell spheroid assays. 
Following this, gGlu-HMJCR and HMRG-based probes, with green fluorescence, were applied 
simultaneously for cancer imaging in vivo with mouse models of peritoneal metastases. By applying 
a cocktail of probes, tumours were labelled depending on their protease activity profiles and emitted 
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fluorescence in either one or both colours. This is the first example known to date of multicolour in 
vivo detection and discrimination of cancer according to the protease activity profile. This imaging 
enabled:  
1. Simultaneous imaging of a wide range of tumours that cannot be characterised with a single 
protease activity. 
2. In vivo distinction of tumours with different protease activity profiles, opening up a possibility 
for early and personalised interventions after surgery.  
3. Multicolour imaging with both probes emitting fluorescence in the visible region that are strong 
enough to be detected by the naked human eye, suggesting good translatability in clinical settings 
such as intraoperative imaging.  
 
The extension of the rational design strategy to silicon-rhodamine (Si-rhodamine) 
derivatives is discussed in Chapter 3. Si-rhodamines are derivatives of rhodamine with the oxygen 
atom at the 10 position replaced with a silicon atom, emitting fluorescence of over 600 nm. A Si-
rhodamine was also reported to have a blue-shift in absorption spectra following amidation of an amine 
on the xanthene moiety, which could contribute to reducing background signals in in vivo imaging, 
but was not fully exploited at the time.  
Since there was only one previous report of a Si-rhodamine bearing a hydroxymethyl group, 
other asymmetrical derivatives were synthesised to examine pKcycl and wavelengths. From these data, 
a novel asymmetrical Si-rhodamine, HMJSiR, was designed and synthesised according to the rational 
design strategy developed in Chapter 2, and was shown to have suitable spectroscopic properties to be 
used as a scaffold for protease probes.  
A GGT probe, gGlu-HMJSiR, was developed based on HMJSiR, with fluorescence in the 
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near infrared region and large activation ratio of over 700 fold utilising both intramolecular 
spirocyclisation and blue-shift in absorption by amidation. Its functions were confirmed by in vitro, in 
cellulo and in vivo fluorescence imaging.   
 
In Chapter 4, the novel protease probes were applied to photoacoustic imaging in cells and 
in clinical specimens. Photoacoustic imaging is an emerging imaging modality with the capability to 
image deeper tissues that are unreachable by fluorescence. gGlu-HMDiMeR and gGlu-HMJSiR were 
both shown to function as GGT-activatable photoacoustic protease probes in cells. Since both GGT 
probes still retain their function as fluorescent probes, dual modality imaging using florescence and 
photoacoustics was possible.  
In the imaging of clinical specimens, clear contrasts between cancerous legions and normal 
tissues were observed in both fluorescence and photoacoustic imaging. Even though there is still room 
for further investigation by immunostaining, the results of pathological analyses, fluorescence imaging 
and photoacoustic imaging were generally in good agreement.  
Further research on contrast agents, hardware and image processing are required for 
photoacoustic imaging to provide convincing results. Nevertheless, these probes showed promising 
characteristics as examples of photoacoustic probes for endogenous protease activities.  
